(PharmaNewsWire.Com, December 06, 2018 ) Preterm birth control market is segmented into treatment method and geography. On the basis of treatment method, the market is segmented into devices and pharmaceutical treatment. The global preterm birth control market is expected to reach US$ 1,809.0 Mn in 2025 from US$ 1,190.5 Mn in 2017. The market is estimated to grow with a CAGR of 4.9% from 2018-2025.
Preterm birth is defined as babies born alive before 37 weeks of pregnancy completion. According to the World Health Organization (WHO), approximately 15 million babies that are victims of preterm birth every years. The identification of women with high risk of preterm birth is a major challenge till date for which various research studies are undergoing at multiple universities, research organizations, and laboratories across the globe. Key factors driving the market are increasing number of preterm births across the world as well as extensive research and development undertaken to bring about new and innovative products. The report would be of an interest to various stakeholders operating in the preterm birth control market. These stakeholders include healthcare institutes, pharmaceutical and biotechnology therapeutics manufactures and suppliers, academic and research institutes, preterm birth control product manufacturers and vendors, research consulting firms, preterm birth control service providers, distributors and others.
The Major Key Market Players:
1. CooperSurgical, Inc. 2. MEDGYN PRODUCTS, INC. 3. Integra LifeSciences Corporation 4. Panpac Medical Corp. 5. Personal Medical Corp 6. Bioteque America, Inc. 7. Bliss GVS Pharma Ltd. 8. Dr. Arabin GmbH & Co. KG 9. AMAG Pharmaceuticals 10. BEN WAY ENTERPRISES SDN BHD
The objective of the study is to describe, define, and forecast the preterm birth control market by treatment method, and region. The report also provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall preterm birth control market.
The report analyzes factors affecting market from both demand and supply side and further evaluates preterm birth control market dynamics effecting the preterm birth control market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key manufacturing companies along with their SWOT analysis and market strategies.
The major players operating in the market include CooperSurgical, Inc., MEDGYN PRODUCTS, INC., Integra LifeSciences, Panpac Medical Corp., Personal Medical Corp, Bioteque America, Inc., Bliss GVS Pharma Ltd., Dr. Arabin GmbH & Co. KG, AMAG Pharmaceuticals, and BEN WAY ENTERPRISES SDN BHD among others. The company players are indulged into development of novel and innovative products to cater the demands of the users in preterm birth control market. For instance, in February 2018, FDA approved Makena a progestin injection by AMAG Pharmaceuticals for the prevention of preterm birth. This market approval is expected to compliment growth and preterm birth control product portfolio of AMAG Pharmaceuticals.
Reason to Buy: Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the preterm birth control market. - Highlights key business priorities in order to assist companies to realign their business strategies. - The key findings and recommendations highlight crucial progressive industry trends in the global preterm birth control market, thereby allowing players across the value chain to develop effective long-term strategies. - Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. - Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it. - Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
The Insight Partners is a one top industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
